Drastop is suitable for people with degenerative diseases of the joints and spinal column. Patients with osteoarthritis of the peripheral joints can be treated with this drug. The medicine is suitable for patients with osteoarthritis and osteochondrosis of the intervertebral discs.
The drug is not suitable for those who have hypersensitivity to the composition of the drug, frequent bleeding, the presence of thrombophlebitis. Not used in the treatment of children. Drastop can be used by persons who drive vehicles and work in enterprises with increased care.
Alflutop is suitable for those diagnosed with: arthrosis of the hip, knee bone joint, arthrosis of small bone joints, osteochondrosis, spondylosis. It is recommended to persons at the time of rehabilitation after injuries and surgical interventions. Assign under the supervision of a specialist to people suffering from autoimmune disorders leading to rheumatoid arthritis, lupus erythematosus, scleroderma, ankylosing spondylitis. In this case, there is a possibility of anaphylactic shock.
The violation of the functionality of the skeletal system takes second place after diseases of the heart and blood vessels. And this is not just statistics. This is a deterioration in the quality of life, constant discomfort, accompanied by pain.
In order to somehow alleviate a painful condition and help a person maintain activity, pharmaceutical companies are developing medical products. One of them is Drastop and Aflutop. To make a choice in favor of one of them, you need to know the features of each.
Drustop
The drug is a corrector of the metabolic processes of bone and cartilage. It belongs to the group of stimulants involved in tissue repair. The main substance involved in all these processes is chondroitin sulfate.
It is produced in the form of a clear solution for intramuscular injection. An ampoule (1 ml) holds 100 mg of the main substance.
Chondroitin sodium sulfate is supplemented with benzyl alcohol, hydrochloric acid, caustic soda.
The drug product acts not only as a stimulant, it has an analgesic effect, relieves inflammation, and regenerates damaged tissues.
The main active component forms the basis of cartilage, bones, enhancing metabolic processes.
Suppresses enzymes that destroy articular cartilage. Due to the main substance, inflammation and pain are reduced. The destruction of bones is suspended, calcium is lost in smaller quantities, joint tissue is restored.
It is proved that the development of osteoarthrosis (damage to the cartilage of the articular surfaces) and osteochondrosis (a complex of structural disorders in the cartilage) are halted. The drug eliminates pain, improves the mobility of bone joints. This effect persists for a long time.
With devastating changes in the joints, including secondary synovitis, relief occurs after three weeks.
In structure, Drastop is similar to heparin, which helps prevent the formation of fibrin blood clots.
The medicine is rapidly absorbed. Accumulates directly in connective tissue. It easily penetrates through the synovial fluid into the cavity of the articular cartilage.
Adverse reactions of the body are not always and not all. Most often these are allergic reactions in the form of:
- Inflammatory skin lesions.
- Intense redness of the skin due to vasodilation of the dermis.
- Painful tickling skin lesions.
An injection at the injection site causes pain and hemorrhage. Sometimes there is swelling of the deep layers of the dermis, indigestion.
If anticoagulants, fibrinolytics, antiplatelet agents are prescribed in parallel, then monitoring of blood coagulation indicators is necessary.
Clinically proven, at least 25 injections are required to achieve treatment effectiveness . The therapeutic result persists for several months. To avoid exacerbation, the course is repeated.
Alflutop
The drug belongs to the means used for pathological disorders of bone joints. The clear injection solution contains a bioactive concentrate from small sea fish. It includes micro / macro elements, chondroitin sulfate, a group of lipid glycerophosphate.
The main effect of the drug is the regulation of metabolic processes in the tissues of cartilage. Due to the substances included in the composition, the drug acts as a chondroprotector, activating the restoration of cartilage structures and preventing the destruction of normal cartilage tissue at the molecular level.
The drug eliminates inflammatory processes and anesthetizes somewhere on the 20th day of therapy.
Alflutop can be prescribed with anesthetics, for example: novocaine – a derivative of PABA. In this case, you need to pay attention to the adverse reactions of the latter.
With the introduction of the drug intramuscularly, sometimes there is hyperemia and burning. With intraarticular injections due to increased metabolism and increased blood circulation, there is a likelihood of increased pain.
Occasionally, due to hypersensitivity, there are:
- Skin rashes.
- Dermatitis.
- Itching
- Edema.
Alflutop is not mixed with other solutions, as there is no evidence of incompatibility.
What is common between drugs
- One dosage form is solutions for injections. Both drugs contain chondroitin sulfate.
- Eliminate inflammation, anesthetize, regenerate and restore connective tissue.
- There are not many adverse reactions, they are rare. Simultaneous administration with other dosage forms is carried out under the supervision of specialists.
- Allergic reactions may occur at the injection site.
- Not used in the treatment of pregnant, lactating women and the children’s group of patients.
Features
There are practically no differences between drugs. Drastop is used for intramuscular injections, and when treated with Alflutop, intramuscular injections are combined with intraarticular injections.
